
OpenAI has lowered its valuation target by $150 billion to $1.25 trillion as it nears final negotiations for a $30 billion funding round, according to Bloomberg, CNBC, and Financial Times reports. The company had previously discussed a $1.4 trillion valuation during recent talks, but the final terms remain subject to change as discussions continue. Coatue Management is in talks to co-lead the round, while OpenAI has also been in discussions with multiple investment funds from the United Arab Emirates, including BlackRock Inc., as reported by Bloomberg. The company expects to have investor commitments finalized by the end of next week, with the proposed valuation excluding the new capital being raised. This represents a significant scaling back from OpenAI's previous $852 billion valuation achieved in March following a record-breaking $122 billion funding round. As per Financial Times, the revised valuation would represent an increase of nearly 50% from the company's current valuation, though investor demand has been weaker than in previous fundraising efforts. Investors have until October 30 to commit to the latest funding round.
The valuation revision comes amid a broader reassessment of AI investments, with technology stocks falling this week following mixed quarterly results from companies including Meta Platforms and Tesla. As reported by Bloomberg, these results have added to investor scrutiny of the scale of spending on artificial intelligence and the returns it may generate. Chief financial officer Sarah Friar told employees in August that the company "will be a public company in 2027", while Chief executive Sam Altman said going public at that point would be "an ill-advised moment" the following month. The company has pushed back its IPO plans until next year, citing its focus on AI safety efforts, having confidentially filed its prospectus with the US Securities and Exchange Commission in June but not disclosing a specific listing date. According to Financial Times, some investors are experiencing funding fatigue after committing substantial sums to AI companies in recent years, while concerns about AI valuations and infrastructure spending are intensifying. Several people close to the process said demand fell short of earlier OpenAI rounds, with one person noting there was "zero clamouring" compared to previous fundraising efforts that saw "a frenzy."
Meanwhile, rival Anthropic is preparing for an IPO expected in mid-November, seeking a valuation of $1.5 trillion to $2 trillion, according to recent reports. Anthropic had previously raised $65 billion in May at a $965 billion valuation before its third-quarter results disappointed investors. The company's filing will give investors their first detailed public look at a frontier AI lab's finances, which could shape how investors compare the two labs heading into 2027. On reported figures, the gap between the two labs has widened to about $250 billion, up from near $100 billion earlier this week. Chinese AI startup DeepSeek has raised about 100 billion yuan ($14.98 billion) in its latest funding round from investors including chipmaker GigaDevice, food delivery company Meituan and automaker Geely, according to sources with knowledge of the matter. DeepSeek, which sources say is valued at 500 billion yuan before new capital is injected, will have doubled its original fundraising target of 50 billion yuan. Competition for funding is another factor shaping OpenAI's plans, with some investors giving a different reason for holding back, stating they would rather see how Anthropic prices its IPO before committing to OpenAI. Jimmy Chang of the Rockefeller Global Family Office said uncertainty around both IPOs is weighing on US stocks, noting "The market needs to see a successful IPO. These companies need funding."
OpenAI is pitching investors on growth that accelerated after the launch of its GPT-6 Astra model, saying it had reached $50 billion in annualized revenue and expecting that figure to rise to $70 billion by year-end. As reported by Reuters, OpenAI has also cut prices on its cheaper models, which it said has boosted usage, and told investors it can further lower the price of AI models. In contrast, Anthropic's annualized revenue reached roughly $65 billion by July, with quarterly revenue jumping to $16.8 billion in the third quarter from $11.6 billion in the second quarter, though slowing month-to-month revenue growth has raised investor concerns about its valuation. The acceleration underscores how closely the two AI developers are competing for capital as both pursue trillion-dollar price tags, amid growing concern about rising interest rates, significant volatility in technology stocks and rising scrutiny of AI valuations. OpenAI may raise less than $30 billion, depending on investor interest, with the October 30 deadline showing how much demand sits at $1.25 trillion before Anthropic sets a public price.
The delayed IPO means OpenAI must keep financing its spending through private markets for at least another year, with its projected cash burn of about $27 billion in 2026, rising to roughly $63 billion in 2027. As reported by Reuters, prediction markets reflect the shift, with the odds of an OpenAI listing by the end of 2027 at a market capitalization above $1.5 trillion falling to about 58%, from roughly 80%. The uncertainty has disrupted what had been expected to be a busy autumn for IPOs, with companies reassessing their listing plans amid market volatility and concerns about valuations. Blackstone-backed AirTrunk REIT, Nvidia-backed Firmus and SoftBank-backed SB Energy have either pulled or paused their listings, while companies in the Philadelphia Semiconductor Index have shed $1.6 trillion in less than two weeks. Nuclear services company Holtec cited a "perfect storm" driven mainly by uncertainty around data-center demand when it pulled its US listing last month. The latest fundraising effort aims to secure up to $30 billion as a bridge to its anticipated initial public offering (IPO), which could take place in the first half of 2027, according to Financial Times. CEO Sam Altman ruled out a 2026 IPO last month, citing safety concerns, while the company's $30 billion target serves as a "bridge" to its own listing.